UnitedHealth Group (NYSE:UNH) Shares Down 0.2%

UnitedHealth Group Incorporated (NYSE:UNHGet Free Report)’s stock price dropped 0.2% during trading on Wednesday . The company traded as low as $481.57 and last traded at $483.57. Approximately 433,017 shares changed hands during trading, a decline of 90% from the average daily volume of 4,136,359 shares. The stock had previously closed at $484.50.

Analyst Ratings Changes

Several equities analysts have issued reports on UNH shares. Erste Group Bank reaffirmed a “hold” rating on shares of UnitedHealth Group in a report on Wednesday, March 13th. StockNews.com cut UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Thursday, June 20th. Royal Bank of Canada decreased their target price on shares of UnitedHealth Group from $596.00 to $555.00 and set an “outperform” rating for the company in a research note on Wednesday, April 17th. JPMorgan Chase & Co. increased their price target on UnitedHealth Group from $546.00 to $559.00 and gave the company an “overweight” rating in a report on Thursday, May 30th. Finally, Robert W. Baird started coverage on UnitedHealth Group in a report on Thursday, May 30th. They set an “outperform” rating and a $597.00 price target on the stock. Three analysts have rated the stock with a hold rating, seventeen have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat.com, UnitedHealth Group has a consensus rating of “Moderate Buy” and a consensus target price of $579.74.

Check Out Our Latest Analysis on UnitedHealth Group

UnitedHealth Group Stock Up 0.5 %

The stock has a market cap of $447.96 billion, a PE ratio of 29.56, a price-to-earnings-growth ratio of 1.41 and a beta of 0.58. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.69. The firm has a fifty day moving average of $498.20 and a 200 day moving average of $502.75.

UnitedHealth Group (NYSE:UNHGet Free Report) last released its quarterly earnings data on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.63 by $0.28. The company had revenue of $99.80 billion during the quarter, compared to the consensus estimate of $99.23 billion. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. UnitedHealth Group’s revenue for the quarter was up 8.6% on a year-over-year basis. During the same quarter in the prior year, the firm posted $6.26 earnings per share. On average, equities research analysts anticipate that UnitedHealth Group Incorporated will post 27.57 EPS for the current fiscal year.

UnitedHealth Group Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, June 25th. Stockholders of record on Monday, June 17th were paid a dividend of $2.10 per share. The ex-dividend date was Monday, June 17th. This is a boost from UnitedHealth Group’s previous quarterly dividend of $1.88. This represents a $8.40 annualized dividend and a dividend yield of 1.73%. UnitedHealth Group’s payout ratio is currently 51.34%.

Institutional Investors Weigh In On UnitedHealth Group

Large investors have recently modified their holdings of the stock. Richelieu Gestion SA acquired a new position in UnitedHealth Group in the fourth quarter worth about $26,000. CGC Financial Services LLC boosted its position in UnitedHealth Group by 1,000.0% during the 4th quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock worth $29,000 after acquiring an additional 50 shares during the period. True Wealth Design LLC acquired a new position in shares of UnitedHealth Group in the 4th quarter worth approximately $31,000. Delos Wealth Advisors LLC boosted its position in shares of UnitedHealth Group by 757.1% in the first quarter. Delos Wealth Advisors LLC now owns 60 shares of the healthcare conglomerate’s stock worth $30,000 after buying an additional 53 shares during the period. Finally, LFA Lugano Financial Advisors SA boosted its stake in shares of UnitedHealth Group by 148.1% during the 4th quarter. LFA Lugano Financial Advisors SA now owns 67 shares of the healthcare conglomerate’s stock valued at $35,000 after buying an additional 40 shares during the period. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Company Profile

(Get Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Featured Articles

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.